-
市場
-
產品
-
資訊
-
Moo社區
-
課堂
-
查看更多
-
功能介紹
-
費用費用透明，無最低余額限制
投資選擇、功能介紹、費用相關信息由Moomoo Financial Inc.提供
- English
- 中文繁體
- 中文简体
- 深色
- 淺色
Tivic Health Systems (NASDAQ:TIVC) Vs. Medtronic (NYSE:MDT) Head-To-Head Contrast
Tivic Health Systems (NASDAQ:TIVC) Vs. Medtronic (NYSE:MDT) Head-To-Head Contrast
Medtronic (NYSE:MDT – Get Rating) and Tivic Health Systems (NASDAQ:TIVC – Get Rating) are both medical companies, but which is the better business? We will compare the two companies based on the strength of their institutional ownership, risk, earnings, profitability, analyst recommendations, dividends and valuation.
Valuation and Earnings
This table compares Medtronic and Tivic Health Systems' gross revenue, earnings per share (EPS) and valuation.
Get Medtronic alerts:| Gross Revenue | Price/Sales Ratio | Net Income | Earnings Per Share | Price/Earnings Ratio | |
| Medtronic | $31.69 billion | 3.47 | $5.04 billion | $3.22 | 25.65 |
| Tivic Health Systems | $1.17 million | 6.12 | -$8.49 million | N/A | N/A |
Medtronic has higher revenue and earnings than Tivic Health Systems.
Risk and Volatility
Medtronic has a beta of 0.72, indicating that its share price is 28% less volatile than the S&P 500. Comparatively, Tivic Health Systems has a beta of 1.87, indicating that its share price is 87% more volatile than the S&P 500.Insider and Institutional Ownership
80.4% of Medtronic shares are held by institutional investors. Comparatively, 0.2% of Tivic Health Systems shares are held by institutional investors. 0.3% of Medtronic shares are held by company insiders. Comparatively, 14.6% of Tivic Health Systems shares are held by company insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a stock is poised for long-term growth.
Profitability
This table compares Medtronic and Tivic Health Systems' net margins, return on equity and return on assets.
| Net Margins | Return on Equity | Return on Assets | |
| Medtronic | 14.03% | 13.52% | 7.77% |
| Tivic Health Systems | -668.17% | -120.72% | -98.51% |
Analyst Recommendations
This is a summary of recent ratings for Medtronic and Tivic Health Systems, as provided by MarketBeat.com.
| Sell Ratings | Hold Ratings | Buy Ratings | Strong Buy Ratings | Rating Score | |
| Medtronic | 1 | 14 | 5 | 0 | 2.20 |
| Tivic Health Systems | 0 | 0 | 0 | 0 | N/A |
Medtronic presently has a consensus target price of $94.25, suggesting a potential upside of 14.13%. Given Medtronic's higher probable upside, analysts plainly believe Medtronic is more favorable than Tivic Health Systems.
Summary
Medtronic beats Tivic Health Systems on 8 of the 11 factors compared between the two stocks.
About Medtronic
(Get Rating)
Medtronic Plc is a medical technology company, which engages in the development, manufacture, distribution, and sale of device-based medical therapies and services. It operates through the following segments: Cardiovascular Porrtfolio, Neuroscience Portfolio, Medical Surgical Portfolio, and Diabetes Operating Unit. The Cardiovascular Portfolio segment includes products for the diagnosis, treatment, and management of cardiac rhythm disorders and cardiovascular disease. The Neuroscience Portfolio is made up of cranial and spinal technologies, specialty therapies, and neuromodulation divisions. The Medical Surgical Portfolio is comprised of surgical innovations and respiratory, gastrointestinal, and renal divisions. The Diabetes Group segment offers insulin pumps, continuous glucose monitoring systems, and insulin pump consumables. The company was founded in 1949 and is headquartered in Dublin, Ireland.
About Tivic Health Systems
(Get Rating)
Tivic Health Systems Inc. operates as a bioelectronic device company that delivers non-invasive neuromodulation products for the treatment of inflammatory conditions. Its primary product is ClearUP, is a medical device intended to relieve sinus and nasal inflammation. The company sells its products on direct-to-consumer channel through its own websites; and platforms, such as Amazon.com and Walmart.com, as well as to U.S. online retailers, including BestBuy.com and FSAStore.com. Tivic Health Systems, Inc. was incorporated in 2016 and is headquartered in Hayward, California.
Receive News & Ratings for Medtronic Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Medtronic and related companies with MarketBeat.com's FREE daily email newsletter.
Medtronic (NYSE:MDT – Get Rating) and Tivic Health Systems (NASDAQ:TIVC – Get Rating) are both medical companies, but which is the better business? We will compare the two companies based on the strength of their institutional ownership, risk, earnings, profitability, analyst recommendations, dividends and valuation.
美敦力(紐約證券交易所代碼：MDT-GET評級)和蒂維奇健康系統(納斯達克：TIVC-GET評級)都是醫療公司，但哪一家更好？我們將根據兩家公司的機構所有權、風險、收益、盈利能力、分析師建議、股息和估值等方面的實力進行比較。
Valuation and Earnings
估值和收益
This table compares Medtronic and Tivic Health Systems' gross revenue, earnings per share (EPS) and valuation.
此表比較了美敦力和Tivic Health Systems的毛收入、每股收益(EPS)和估值。
| Gross Revenue | Price/Sales Ratio | Net Income | Earnings Per Share | Price/Earnings Ratio | |
| Medtronic | $31.69 billion | 3.47 | $5.04 billion | $3.22 | 25.65 |
| Tivic Health Systems | $1.17 million | 6.12 | -$8.49 million | N/A | N/A |
| 總收入 | 價格/銷售額比 | 淨收入 | 每股收益 | 市盈率 | |
| 美敦力 | 316.9億美元 | 3.47 | 50.4億美元 | $3.22 | 25.65 |
| Tivic Health Systems | 117萬美元 | 6.12 | -849萬元 | 不適用 | 不適用 |
Medtronic has higher revenue and earnings than Tivic Health Systems.
美敦力的收入和收益高於Tivic Health Systems。
Risk and Volatility
風險和波動性
Insider and Institutional Ownership
內部人與機構持股
80.4% of Medtronic shares are held by institutional investors. Comparatively, 0.2% of Tivic Health Systems shares are held by institutional investors. 0.3% of Medtronic shares are held by company insiders. Comparatively, 14.6% of Tivic Health Systems shares are held by company insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a stock is poised for long-term growth.
美敦力80.4%的股份由機構投資者持有。相比之下，Tivic Health Systems 0.2%的股份由機構投資者持有。美敦力0.3%的股份由公司內部人士持有。相比之下，Tivic Health Systems 14.6%的股份由公司內部人士持有。強大的機構持股表明，對衝基金、捐贈基金和大型基金管理公司相信，一隻股票有望實現長期增長。
Profitability
盈利能力
This table compares Medtronic and Tivic Health Systems' net margins, return on equity and return on assets.
此表比較了美敦力和Tivic Health Systems的淨利潤率、股本回報率和資產回報率。
| Net Margins | Return on Equity | Return on Assets | |
| Medtronic | 14.03% | 13.52% | 7.77% |
| Tivic Health Systems | -668.17% | -120.72% | -98.51% |
| 淨利潤率 | 股本回報率 | 資產回報率 | |
| 美敦力 | 14.03% | 13.52% | 7.77% |
| Tivic Health Systems | -668.17% | -120.72% | -98.51% |
Analyst Recommendations
分析師建議
This is a summary of recent ratings for Medtronic and Tivic Health Systems, as provided by MarketBeat.com.
這是由MarketBeat.com提供的美敦力和Tivic Health Systems最近的評級摘要。
| Sell Ratings | Hold Ratings | Buy Ratings | Strong Buy Ratings | Rating Score | |
| Medtronic | 1 | 14 | 5 | 0 | 2.20 |
| Tivic Health Systems | 0 | 0 | 0 | 0 | N/A |
| 銷售評級 | 保持評級 | 購買評級 | 強勁的買入評級 | 評級分數 | |
| 美敦力 | 1 | 14 | 5 | 0 | 2.20 |
| Tivic Health Systems | 0 | 0 | 0 | 0 | 不適用 |
Medtronic presently has a consensus target price of $94.25, suggesting a potential upside of 14.13%. Given Medtronic's higher probable upside, analysts plainly believe Medtronic is more favorable than Tivic Health Systems.
美敦力目前的普遍目標價為94.25美元，這意味着潛在的上漲幅度為14.13%。考慮到美敦力更有可能的上行空間，分析師們顯然認為美敦力比Tivic Health Systems更有利。
Summary
摘要
Medtronic beats Tivic Health Systems on 8 of the 11 factors compared between the two stocks.
美敦力在兩隻股票比較的11個因素中有8個擊敗了Tivic Health Systems。
About Medtronic
美敦力簡介
(Get Rating)
(獲取評級)
Medtronic Plc is a medical technology company, which engages in the development, manufacture, distribution, and sale of device-based medical therapies and services. It operates through the following segments: Cardiovascular Porrtfolio, Neuroscience Portfolio, Medical Surgical Portfolio, and Diabetes Operating Unit. The Cardiovascular Portfolio segment includes products for the diagnosis, treatment, and management of cardiac rhythm disorders and cardiovascular disease. The Neuroscience Portfolio is made up of cranial and spinal technologies, specialty therapies, and neuromodulation divisions. The Medical Surgical Portfolio is comprised of surgical innovations and respiratory, gastrointestinal, and renal divisions. The Diabetes Group segment offers insulin pumps, continuous glucose monitoring systems, and insulin pump consumables. The company was founded in 1949 and is headquartered in Dublin, Ireland.
美敦力是一家醫療科技公司，從事基於設備的醫療治療和服務的開發、製造、分銷和銷售。它通過以下部門運作：心血管Porrtfolio、神經科學投資組合、醫療外科投資組合和糖尿病運營部門。心血管產品組合包括心律失常和心血管疾病的診斷、治療和管理產品。神經科學產品組合由顱腦和脊柱技術、專業治療和神經調節部門組成。醫療外科產品組合包括外科創新以及呼吸系統、胃腸道和腎臟部門。糖尿病組部門提供胰島素泵、連續血糖監測系統和胰島素泵消耗品。該公司成立於1949年，總部設在愛爾蘭都柏林。
About Tivic Health Systems
關於Tivic Health Systems
(Get Rating)
(獲取評級)
Tivic Health Systems Inc. operates as a bioelectronic device company that delivers non-invasive neuromodulation products for the treatment of inflammatory conditions. Its primary product is ClearUP, is a medical device intended to relieve sinus and nasal inflammation. The company sells its products on direct-to-consumer channel through its own websites; and platforms, such as Amazon.com and Walmart.com, as well as to U.S. online retailers, including BestBuy.com and FSAStore.com. Tivic Health Systems, Inc. was incorporated in 2016 and is headquartered in Hayward, California.
Tivic Health Systems Inc.是一家生物電子設備公司，提供用於治療炎症情況的非侵入性神經調節產品。它的主要產品是Clearup，是一種旨在緩解鼻竇和鼻部炎症的醫療設備。該公司通過自己的網站、亞馬遜(Amazon.com)和沃爾瑪(Walmart.com)等平臺以及BestBuy.com和FSAStore.com等美國在線零售商，通過直接面向消費者的渠道銷售產品。Tivic Health Systems，Inc.成立於2016年，總部設在加利福尼亞州海沃德。
Receive News & Ratings for Medtronic Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Medtronic and related companies with MarketBeat.com's FREE daily email newsletter.
接受美敦力日報的新聞和評級-在下面輸入您的電子郵件地址，通過MarketBeat.com的免費每日電子郵件時事通訊接收最新新聞和分析師對美敦力及相關公司評級的每日摘要。
moomoo是Moomoo Technologies Inc.公司提供的金融資訊和交易應用程式。
在美國，moomoo上的投資產品和服務由Moomoo Financial Inc.提供，一家受美國證券交易委員會（SEC）監管的持牌主體。 Moomoo Financial Inc.是金融業監管局（FINRA）和證券投資者保護公司（SIPC）的成員。
在新加坡，moomoo上的投資產品和服務是通過Moomoo Financial Singapore Pte. Ltd.提供，該公司受新加坡金融管理局（MAS）監管(牌照號碼︰CMS101000) ，持有資本市場服務牌照 (CMS) ，持有財務顧問豁免（Exempt Financial Adviser）資質。本內容未經新加坡金融管理局的審查。
在澳大利亞，moomoo上的金融產品和服務是通過Futu Securities (Australia) Ltd提供，該公司是受澳大利亞證券和投資委員會(ASIC)監管的澳大利亞金融服務許可機構（AFSL No. 224663）。請閱讀並理解我們的《金融服務指南》、《條款與條件》、《隱私政策》和其他披露文件，這些文件可在我們的網站 https://www.moomoo.com/au中獲取。
在加拿大，透過moomoo應用程式提供的僅限訂單執行的券商服務由Moomoo Financial Canada Inc.提供，並受加拿大投資監管機構（CIRO）監管。
在馬來西亞，moomoo上的投資產品和服務是透過Moomoo Securities Malaysia Sdn. Bhd. 提供，該公司受馬來西亞證券監督委員會（SC）監管(牌照號碼︰eCMSL/A0397/2024) ，持有資本市場服務牌照 (CMSL) 。本內容未經馬來西亞證券監督委員會的審查。
Moomoo Technologies Inc., Moomoo Financial Inc., Moomoo Financial Singapore Pte. Ltd.，Futu Securities (Australia) Ltd, Moomoo Financial Canada Inc和Moomoo Securities Malaysia Sdn. Bhd., 是關聯公司。
風險及免責聲明
moomoo是Moomoo Technologies Inc.公司提供的金融資訊和交易應用程式。
在美國，moomoo上的投資產品和服務由Moomoo Financial Inc.提供，一家受美國證券交易委員會（SEC）監管的持牌主體。 Moomoo Financial Inc.是金融業監管局（FINRA）和證券投資者保護公司（SIPC）的成員。
在新加坡，moomoo上的投資產品和服務是通過Moomoo Financial Singapore Pte. Ltd.提供，該公司受新加坡金融管理局（MAS）監管(牌照號碼︰CMS101000) ，持有資本市場服務牌照 (CMS) ，持有財務顧問豁免（Exempt Financial Adviser）資質。本內容未經新加坡金融管理局的審查。
在澳大利亞，moomoo上的金融產品和服務是通過Futu Securities (Australia) Ltd提供，該公司是受澳大利亞證券和投資委員會(ASIC)監管的澳大利亞金融服務許可機構（AFSL No. 224663）。請閱讀並理解我們的《金融服務指南》、《條款與條件》、《隱私政策》和其他披露文件，這些文件可在我們的網站 https://www.moomoo.com/au中獲取。
在加拿大，透過moomoo應用程式提供的僅限訂單執行的券商服務由Moomoo Financial Canada Inc.提供，並受加拿大投資監管機構（CIRO）監管。
在馬來西亞，moomoo上的投資產品和服務是透過Moomoo Securities Malaysia Sdn. Bhd. 提供，該公司受馬來西亞證券監督委員會（SC）監管(牌照號碼︰eCMSL/A0397/2024) ，持有資本市場服務牌照 (CMSL) 。本內容未經馬來西亞證券監督委員會的審查。
Moomoo Technologies Inc., Moomoo Financial Inc., Moomoo Financial Singapore Pte. Ltd.，Futu Securities (Australia) Ltd, Moomoo Financial Canada Inc和Moomoo Securities Malaysia Sdn. Bhd., 是關聯公司。
- 分享到weixin
- 分享到qq
- 分享到facebook
- 分享到twitter
- 分享到微博
- 粘贴板
使用瀏覽器的分享功能，分享給你的好友吧